Literature DB >> 27833938

Effect of Glucose on Retinal Endothelial Cell Viability and VEGF Secretion.

Brandi S Betts-Obregon1, Sandeep Vellanki1, Jessica Buikema1, Andrew T Tsin1, Keli Wright2.   

Abstract

Previous studies have shown that in diabetic patients, there is an increase of retinal capillaries associated with the development of diabetic retinopathy in the eye. The objective of current study is to investigate the effect of glucose on retinal endothelial cell viability and VEGF secretion. 20,000 cells per well were treated without glucose or with 5.5mM (euglycemic), 18.5mM and 30mM (hyperglycemic) glucose for 24 hours. Viable cells were counted using Trypan blue dye exclusion method. ELISA was used to measure VEGF secretion from cells into the cell medium. The number of viable cells incubated with 5.5mM glucose (physiological control) increased by 53.7% after 24 hours. In comparison, cells treated with 18.5mM glucose decreased by 2.8% while cells treated with 30mM glucose decreased by 20% after 24 hours of incubation. Cells without glucose treatment (0mM control) decreased by 33.3%. In contrast to the decrease of viable cell numbers after treatment with high glucose, there is an increase in VEGF secretion (pg/mL) to the cell medium with increase in glucose concentration from 5.5mM to 0, 18.5, and 30mM. The amount of VEGF secreted per cell also increased with increasing glucose concentrations. Our results show that viability of retinal endothelial cells and VEGF release are highly responsive to changes in glucose concentration. Such glucose-induced changes in retinal endothelial cells may negatively impact the integrity of the microvasculature in the diabetic retina leading to angiogenesis and microaneursyms.

Entities:  

Keywords:  Diabetic retinopathy; Glucose; Retina; Retinal endothelial cell; VEGF

Year:  2016        PMID: 27833938      PMCID: PMC5100359     

Source DB:  PubMed          Journal:  HSOA J Cell Biol Cell Metabol        ISSN: 2381-1943


  18 in total

1.  The role of vascular endothelial growth factor gene as the genetic marker of atherothrombotic disorders and in the gene therapy of coronary artery disease.

Authors:  Daniel Petrovic
Journal:  Cardiovasc Hematol Agents Med Chem       Date:  2010-01

2.  A common polymorphism in the 5'-untranslated region of the VEGF gene is associated with diabetic retinopathy in type 2 diabetes.

Authors:  Takuya Awata; Kiyoaki Inoue; Susumu Kurihara; Tomoko Ohkubo; Masaki Watanabe; Kouichi Inukai; Ikuo Inoue; Shigehiro Katayama
Journal:  Diabetes       Date:  2002-05       Impact factor: 9.461

3.  ARPE-19 cell growth and cell functions in euglycemic culture media.

Authors:  Ernest G Heimsath; Richard Unda; Eileen Vidro; Albert Muniz; Elia T Villazana-Espinoza; Andrew Tsin
Journal:  Curr Eye Res       Date:  2006-12       Impact factor: 2.424

4.  The prevalence of diabetic retinopathy among adults in the United States.

Authors:  John H Kempen; Benita J O'Colmain; M Cristina Leske; Steven M Haffner; Ronald Klein; Scot E Moss; Hugh R Taylor; Richard F Hamman
Journal:  Arch Ophthalmol       Date:  2004-04

5.  High Glucose and Glucose Deprivation Modulate Müller Cell Viability and VEGF Secretion.

Authors:  S Vellanki; A Ferrigno; Y Alanis; B S Betts-Obregon; A T Tsin
Journal:  Int J Ophthalmol Eye Sci       Date:  2016-02-15

6.  Glucose and TGFbeta2 modulate the viability of cultured human retinal pericytes and their VEGF release.

Authors:  Eileen K Vidro; Stephen Gee; Richard Unda; Jian-xing Ma; Andrew Tsin
Journal:  Curr Eye Res       Date:  2008-11       Impact factor: 2.424

7.  Global estimates of the prevalence of diabetes for 2010 and 2030.

Authors:  J E Shaw; R A Sicree; P Z Zimmet
Journal:  Diabetes Res Clin Pract       Date:  2009-11-06       Impact factor: 5.602

8.  Scutellarin inhibits high glucose-induced and hypoxia-mimetic agent-induced angiogenic effects in human retinal endothelial cells through reactive oxygen species/hypoxia-inducible factor-1α/vascular endothelial growth factor pathway.

Authors:  Difei Wang; Lei Wang; Jianqiu Gu; Huijing Yang; Nanqi Liu; Yichen Lin; Xiaolin Li; Chen Shao
Journal:  J Cardiovasc Pharmacol       Date:  2014-09       Impact factor: 3.105

Review 9.  Diabetes and associated complications in the South Asian population.

Authors:  Arti Shah; Alka M Kanaya
Journal:  Curr Cardiol Rep       Date:  2014-05       Impact factor: 2.931

10.  Local and genetic determinants of vascular endothelial growth factor expression in advanced proliferative diabetic retinopathy.

Authors:  Mojca Globocnik Petrovic; Peter Korosec; Mitja Kosnik; Josko Osredkar; Marko Hawlina; Borut Peterlin; Daniel Petrovic
Journal:  Mol Vis       Date:  2008-07-30       Impact factor: 2.367

View more
  2 in total

1.  Kaempferol targets estrogen-related receptor α and suppresses the angiogenesis of human retinal endothelial cells under high glucose conditions.

Authors:  Yan Wu; Qinmei Zhang; Rui Zhang
Journal:  Exp Ther Med       Date:  2017-10-03       Impact factor: 2.447

2.  βA1-crystallin regulates glucose metabolism and mitochondrial function in mouse retinal astrocytes by modulating PTP1B activity.

Authors:  Haitao Liu; Meysam Yazdankhah; Nadezda Stepicheva; Peng Shang; Sayan Ghosh; Tanuja Vaidya; Stacey Hose; Urvi Gupta; Michael Joseph Calderon; Ming-Wen Hu; Archana Padmanabhan Nair; Joseph Weiss; Christopher S Fitting; Imran A Bhutto; Santosh Gopi Krishna Gadde; Naveen Kumar Naik; Chaitra Jaydev; Gerard A Lutty; James T Handa; Ashwath Jayagopal; Jiang Qian; José-Alain Sahel; Dhivyaa Rajasundaram; Yuri Sergeev; J Samuel Zigler; Swaminathan Sethu; Simon Watkins; Arkasubhra Ghosh; Debasish Sinha
Journal:  Commun Biol       Date:  2021-02-24
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.